The Place of Combination Therapy in the Treatment of Hypertension in 1993

References

• Management Committee of the Australian Therapeutic Trial in Mild Hypertension. The Australian Therapeutic Trial in Mild Hypertension. Lancet 1980; 1: 1261–1271
   PubMed Web of Science ®Google Scholar
• Hypertension Detection and Follow-up Program Cooperative Group. Give year findings of the Hypertension Detection and Follow-up Program: I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979; 242: 2562–2572
   PubMed Web of Science ®Google Scholar
• The IPPPSH Collaborative Group. Cardiovascular risk and raisk factors in a randomised trial of treatment based on the beta blocker Oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH). J Hypertens 1985; 379–392
   PubMed Web of Science ®Google Scholar
• Amery A, Birkenhäger W, Brixko P, et al. Mortality and morbidity results from the European Working Party on high blood pressure in the elderly trial. Lancet 1985; i: 1349–1354
   Google Scholar
• MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992; 304: 405–412
   PubMed Web of Science ®Google Scholar
• SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255–3264
   PubMed Web of Science ®Google Scholar
• Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish Trial in old patients with hypertension (STOP-hypertension). Lancet 1991; 338: 1281–1285
   PubMed Web of Science ®Google Scholar
• Coope J. Randomized trial of treatment of hypertension in elderly patients in primary care. Br Med J 1986; 293: 1145–1151
   PubMed Web of Science ®Google Scholar
• Brunner HR, Menard J. Treating the individual hypertensive patient: Considerations on dose, sequential monotherapy and drug combinations. J Hypertens 1990; 8: 3–12
   PubMed Web of Science ®Google Scholar
• Cappuccio FP, MacGregor GA. Combination therapy in hypertension. J Human Hypertens 1991; 5(Suppl 2)9–15
   PubMedGoogle Scholar
• Hansson L, Himmelmann A. Calcium antagonists in antihypertensive combination therapy. J Cardiovasc Pharmacol 1991; 18(10)S76–S80
   PubMedGoogle Scholar
• Medical Research Council Working Party. MRC trial of treatment of mild hypertension: Principal results. Br Med J 1985; 291: 97–104
   PubMed Web of Science ®Google Scholar
• Johnston Cl, Arnolda L, Hiwalari M. Angiotensin-converting enzyme inhibitors in the treatment of hypertension. Drugs 1984; 27: 271–277
   PubMed Web of Science ®Google Scholar
• Chalmers JP. Effects of enalapril and hydrochlorothiazide on blood pressure, renin-angiotensin system and atrial natriuretic factor in essential hypertension. A double blind factorial cross-over study. ANZ J Med 1986; 16: 475–480
   Web of Science ®Google Scholar
• Dahlöf B, Eggertsen R, Hansson L. Calcium antagonists combined with ß-blockers or ACE inhibitors in the treatment of hypertension. J Cardiovasc Pharmacol 1988; 12(6)S104–S108
   PubMedGoogle Scholar
• Salvetti A, Innocenti PF, Lardella M, et al. Captopril and Nifedipine interactions in the treatment of essential hypertensives: a crossover study. J Hypertens 1987; 5(4)S139–S142
   Google Scholar
• Singer D RJ, Markandu ND, Shore A. Captopril and Nifedipine in combination for moderate to severe hypertension. Hypertension 1987; 9: 629–633
   PubMed Web of Science ®Google Scholar
• Wing L MH, Chalmers JP, West MJ, et al. Enalapril and atenolol in essential hypertension: Attenuation of hypotensive effects in combination. Clin Exp Hypertension 1988; A10(1)119–133
   Google Scholar
• Wing L MH, Chalmers JP, West MJ, et al. Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: contrasts in hypotensive interactions. J Hypertens 1987; 5(5)S603–S606
   Google Scholar
• Zanchetti A. Angiotensin-converting enzyme inhibitors in essential hypertension. J Cardiovasc Pharmacol 1987; 9(Suppl 3)S2–S5
   PubMedGoogle Scholar
• Mac Gregor GA, Markandu NG, Smith SJ, Sagnella G A. Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine. J Cardiovasc Pharmacol 1985; 7(Suppl 1)S82–S87
   Google Scholar
• Pickering TG, Case DB, Sullivan PA, Laragh JH. Comparison of antihypertensive and hormonal effects of captopril and propranolol at rest and during exercise. Am J Cardiol 1982; 49: 1566–1568
   PubMed Web of Science ®Google Scholar
• Staessen J, Fagard R, Lijnen P, Verschueren LJ, Amery A. The hypotensive effects of propranolol in captopril-treated patients does not involve the plasma renin-angiotensin-aldosterone system. Clin Sci 1981; 61(Suppl 7)S441–S444
   Google Scholar
• Staessen J, Fagard R, Lijnen P, Verschueren LJ, Amery A. Double blind comparison between propranolol and bendroflumethiazide in captopril-treated resistant hypertensive patients. Am Heart J 1983; 106: 321–328
   PubMed Web of Science ®Google Scholar
• Belz GG, Breithaupt K, Erb K, Kleinbloesam CH. Influence of the angiotensin converting enzyme inhibitor cilazapril, the beta blocker propranolol and their combination on haemodynamics in hypertension. J Hypertens 1989; 7: 817–824
   PubMed Web of Science ®Google Scholar
• Salvetti A, Magagna A, Innocenti P, et al. Chlorthalidone does not increase the hypotensive effect of Nifedipine in essential hypertensives: a crossover multicentre study. J Hypertens 1989; 7(6)S250–S251
   Google Scholar
• Ritz E, Schmid M, Ji-Zhen G, Mann J. Salt and action of calcium antagonists. J Cardiovasc Pharmacol 1988; 12(6)S53–S56
   PubMedGoogle Scholar
• Cappuccio FP, MacGregor G A. Combination therapy in hypertension. J Human Hypertens 1991; 8(2)144–152
   Google Scholar
• Glasser SP, Chrysant SG, Graves J, Rofman B, Koehn D. Safety and efficacy of Amlodipine added to hydrochlorothiazide therapy in essential hypertension. Amer J Hypertens 1989; 2: 154–157
   PubMed Web of Science ®Google Scholar
• Hallin L, Andress L, Hansson L. Controlled trial of Nifedipine and Bendroflumethiazide in hypertension. J Cardiovasc Pharmacol 1983; 5: 1083–1085
   PubMed Web of Science ®Google Scholar
• Pasanisi F, Elliott HL, Meredith PA, Sherry, Dr, Reid J L. Combined alpha adrenoceptor antagonism and calcium channel blockade in normal subjects. Clin Pharmacol Ther 1984; 36: 716–723
   PubMed Web of Science ®Google Scholar
• Wing LM, Russell AE, Tonkin AL, et al. Felodipine, enalapril and their combination compared with placebo in isolated systolic hypertension in the elderly, (submitted for publication)
   Google Scholar
• Wing LM, Russell AE, Tonkin AL, Bune AJ, West MJ, Chalmers J P. Felodipine, metoprolol and their combination compared with placebo in isolated systolic hypertension in the elderly, (submitted for publication)
   Google Scholar